Eleni Douni Selected Research

Phospholipases (Phospholipase)

1/2009

Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleni Douni Research Topics

Disease

6	Osteoporosis 07/2023 - 07/2013
5	Bone Resorption 07/2023 - 02/2012
5	Arthritis (Polyarthritis) 12/2015 - 01/2004
2	Neoplasms (Cancer) 08/2023 - 01/2020
2	Postmenopausal Osteoporosis 10/2020 - 01/2014
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2019 - 01/2014
2	Crohn Disease (Crohn's Disease) 01/2018 - 11/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2018
2	Disease Progression 12/2015 - 11/2002
2	Osteoarthritis 01/2009 - 01/2004
2	Rheumatoid Arthritis 01/2009 - 01/2004
2	Synovitis 01/2004 - 01/2004
1	Carcinogenesis 08/2023
1	Breast Neoplasms (Breast Cancer) 08/2023
1	Weight Gain 12/2021
1	Metabolic Diseases (Metabolic Disease) 12/2021
1	Hyperinsulinism (Hyperinsulinemia) 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Anorexia 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 01/2019
1	Atrophy 01/2019
1	Insulin Resistance 01/2019
1	Muscle Weakness 01/2019
1	Sarcopenia 01/2019
1	Asthma (Bronchial Asthma) 01/2018
1	Multiple Sclerosis 01/2018
1	Psoriatic Arthritis 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Ataxia (Dyssynergia) 01/2017
1	Pontocerebellar Hypoplasia 01/2017
1	Leigh Disease (Leigh's Disease) 01/2017
1	Optic Atrophy 01/2017
1	Bone Diseases (Bone Disease) 01/2014
1	Osteopetrosis 02/2012
1	Inflammation (Inflammations) 01/2009
1	Ischemia 01/2003
1	Central Nervous System Diseases (CNS Diseases) 01/2003
1	Colitis 11/2002
1	Wasting Syndrome (Wasting Disease) 11/2002

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 08/2023 - 02/2012
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2002
2	Denosumab FDA Link 08/2023 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2004
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2009
2	CytokinesIBA 07/2013 - 11/2002
2	Secretory Phospholipases A2IBA 01/2009 - 01/2004
2	Peptides (Polypeptides)IBA 01/2009 - 01/2004
1	Progestins (Progestagens)IBA 08/2023
1	Hormones (Hormone)IBA 08/2023
1	GlucocorticoidsIBA 12/2021
1	Insulin (Novolin)FDA Link 12/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	ThiazolidinedionesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	MyostatinIBA 01/2019
1	RANK LigandIBA 01/2018
1	Tumor Necrosis Factor InhibitorsIBA 01/2018
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2017
1	Etanercept (Enbrel)FDA Link 12/2015
1	Phosphotransferases (Kinase)IBA 12/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2014
1	Essential Amino AcidsIBA 02/2012
1	Matrix Metalloproteinase InhibitorsIBA 01/2009
1	Phospholipases (Phospholipase)IBA 01/2009
1	InterleukinsIBA 01/2009
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2009
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2009
1	TristetraprolinIBA 10/2006
1	Arachidonic Acid (Vitamin F)IBA 01/2004
1	Dinoprostone (PGE2)FDA Link 01/2004
1	Therapeutic UsesIBA 01/2004
1	Methotrexate (Mexate)FDA LinkGeneric 01/2004
1	Phospholipases A2 (Phospholipase A2)IBA 01/2004
1	diacereinIBA 01/2004
1	LipopolysaccharidesIBA 01/2004
1	ProstaglandinsIBA 01/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2002

Therapy/Procedure

3	Therapeutics 08/2023 - 01/2004
1	Drug Therapy (Chemotherapy) 01/2020
1	Denervation 01/2019